Sanyal AJ, Taubel J, Badri P, Bond S, et al. Phase 1 randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis. J Hepatol 2025 Jun 26:S0168-8278(25)02270-6. doi: 10.1016/j.jhep.2025.
PMID: 40581300